Neetyabhas: A Framework for Uncertainty-Aware Public Policy Optimization in Rational Agent-Based Models
Purpose The WHO's COVID-19 non-pharmaceutical interventions (e. g.
arXiv:2606. 04562v1 Announce Type: new Abstract: Purpose The WHO's COVID-19 non-pharmaceutical interventions (e.
Purpose The WHO's COVID-19 non-pharmaceutical interventions (e. g.
arXiv:2605. 26704v2 Announce Type: replace-cross Abstract: Epidemic forecasting faces a fundamental challenge: human behavior dynamically responds to disease spread, creating feedback loops that induce distribution shifts at policy intervention points.
arXiv:2606. 05692v1 Announce Type: new Abstract: Deep learning has enabled significant advances in time-series causal inference, yet progress remains constrained by the lack of realistic benchmarks with observable counterfactual outcomes.
arXiv:2607. 08793v1 Announce Type: cross Abstract: Sepsis is a leading cause of mortality, yet optimal treatment policies remain contested.
arXiv:2607. 16916v1 Announce Type: new Abstract: Bladder cancer treatment requires personalized and adaptive decision-making, particularly for recurrent disease, where treatment effectiveness changes across successive clinical episodes.
arXiv:2508. 03875v2 Announce Type: replace Abstract: Many sequential decision problems offer qualitatively different ways of influencing the environment: some interventions act immediately, whereas others induce persistent effects that continue to shape future states long after the decision that initiated them.
arXiv:2606. 02867v1 Announce Type: cross Abstract: Human behaviour during epidemics affects infectious disease dynamics, but quantifying this remains deeply challenging.
Deep learning has enabled significant advances in time-series causal inference, yet progress remains constrained by the lack of realistic benchmarks with observable counterfactual outcomes. Existing datasets either rely on real-world observations without ground-truth counterfactuals or on simplified simulations that fail to capture complex causal dynamics.
arXiv:2608. 03606v1 Announce Type: new Abstract: Clinical development is sequential decision-making under uncertainty, where a sponsor must plan a portfolio of experiments from heterogeneous evidence.
arXiv:2607. 06757v1 Announce Type: new Abstract: Agent-based modeling (ABM) has the capability to model millions of individuals and their interactions, which is useful for policy making.
arXiv:2606. 10228v1 Announce Type: cross Abstract: Safe exploration is a prerequisite for deploying reinforcement learning (RL) agents in safety-critical domains.
arXiv:2608. 11410v1 Announce Type: new Abstract: Offline reinforcement learning (RL) offers considerable promise for optimizing ICU treatment decisions, yet standard evaluation metrics Mean Squared Error (MSE) and Fitted Q-Evaluation (FQE) assess only behavioral imitation and cannot detect Toxic Mimicry, a failure mode in which agents replicate harmful patterns such as treatment withdrawal during comfort-care transitions.